About this trial
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.
Eligibility criteria
Qualifiers
Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
Squamous cell carcinoma or other histological types;
WHO ≤ 2;
Ability to complete validated questionnaires in French;
Disqualifiers
Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;
Patient under juridic protection;
Pregnant or breastfeeding woman
Trial design
Treatments tested in this trial
- Prospective questionnaires